Substituted isoquinoline and isoquinolinone derivatives
申请人:Plettenburg Oliver
公开号:US08772492B2
公开(公告)日:2014-07-08
The invention relates to 6-substituted isoquinoline and isoquinoline derivatives of the formula (I)
useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
SUBSTITUTED ISOQUINOLINES AND THEIR USE AS RHO-KINASE INHIBITORS
申请人:Sanofi-Aventis
公开号:EP2132194A2
公开(公告)日:2009-12-16
US8772492B2
申请人:——
公开号:US8772492B2
公开(公告)日:2014-07-08
[EN] NEW SUBSTITUTED ISOQUINOLINE AND ISOQUINOLINONE DERIVATIVES<br/>[FR] NOUVEAUX DÉRIVÉS D'ISOQUINOLINE ET D'ISOQUINOLINONE SUBSTITUÉS
申请人:SANOFI AVENTIS
公开号:WO2008077555A2
公开(公告)日:2008-07-03
[EN] The invention relates to 6-substituted isoquinoline and isochinolone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds. [FR] L'invention concerne des dérivés d'isoquinoline et d'isoquinolone 6-substitués représentés par la formule (I), utilisés dans le traitement et/ou la prévention de maladies associées à la Rho-kinase et/ou à la phosphorylation médiée par la Rho-kinase de la phosphatase de la chaîne légère de la myosine, et des compositions contenant lesdits composés.
New substituted isoquinoline and isoquinolinone derivatives
申请人:PLETTENBURG Oliver
公开号:US20100056566A1
公开(公告)日:2010-03-04
The invention relates to 6-substituted isoquinoline and isochinolone derivatives of the formula (I)
useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.